Cargando…
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
The treatment and prognosis of advanced colorectal cancer (CRC) remain a challenging clinical research focus. Here, we describe a new CRC tumor suppressor and potential therapeutic target: thymocyte selection associated high mobility group box (TOX) protein. The expression of TOX was lower in CRC th...
Autores principales: | Yang, Mengdi, Huang, Qianru, Li, Changcan, Jiang, Zhiyuan, Sun, Jing, Wang, Zhiyu, Liang, Rui, Li, Dan, Li, Bin, Zhao, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062716/ https://www.ncbi.nlm.nih.gov/pubmed/33897695 http://dx.doi.org/10.3389/fimmu.2021.647540 |
Ejemplares similares
-
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017) -
The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance
por: Li, Jiawei, et al.
Publicado: (2021) -
EMP2 acts as a suppressor of melanoma and is negatively regulated by mTOR-mediated autophagy
por: Wang, Manyi, et al.
Publicado: (2019) -
All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012) -
Akt and mTOR in B Cell Activation and Differentiation
por: Limon, Jose J., et al.
Publicado: (2012)